Destin store makes holiday weekend a little sweeter for veteran Truliever

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States, announced today that it had its first TruChocolate sale of edible cannabis in Destin, Florida on Saturday, September 5, the morning after approval. Trulieve received approval for its first edible product on September 2 and was first in the state to sell an edible product. Today’s sale continues the Company’s edible firsts with the first sale of Trulieve’s TruChocolate as well as its first partner products.

Long-time Truliever and US Air Force veteran Brian Schiefer is joined by Kim Rivers, CEO; Renee Legere, Trulieve Community Educator; and Dr. Eddie Zant as Brian makes first edibles purchase of TruChocolate Bars plus Love’s Oven’s chocolate chip cookies and brownies in Florida on Saturday, September 5, 2020, at Trulieve’s Destin dispensary. (CNW Group/Trulieve Cannabis Corp.)

Long-time Truliever and US Air Force veteran Brian Schiefer is joined by Kim Rivers, CEO; Renee Legere, Trulieve Community Educator; and Dr. Eddie Zant as Brian makes first edibles purchase of TruChocolate Bars plus Love’s Oven’s chocolate chip cookies and brownies in Florida on Saturday, September 5, 2020, at Trulieve’s Destin dispensary. (CNW Group/Trulieve Cannabis Corp.)

Photo caption: Long-time Truliever and US Air Force veteran Brian Schiefer is joined by Kim Rivers, CEO; Renee Legere, Trulieve Community Educator; and Dr. Eddie Zant as Brian makes first edibles purchase of TruChocolate Bars plus Love’s Oven’s chocolate chip cookies and brownies in Florida on Saturday, September 5, 2020, at Trulieve’s Destin dispensary.

As batches are tested and shipments begin leaving the production facilities, the Destin store became the first to receive delivery and introduce TruChocolate, as well as partner brand Love’s Oven’s Chocolate Chip Cookies and 1:1 Fudge Brownies to the Florida market. The September 5th sale continues Trulieve’s long record of firsts in the state and shows its commitment to providing quick, direct access to edibles to its Florida patients.

“We were thrilled to have received approval from the DOH just before the long holiday weekend and quickly focused on getting product to a store. There has been strong demand for medication in this format and we look forward to celebrating each new product and partner offering with our Trulievers as a way to spread the sweetness in different communities,” said Kim Rivers, CEO of Trulieve. “Last week, we were able to bring the first edible to the market, delivering our Blue Raspberry TruGels to 17 of our stores. For our remaining 40 stores, we worked hard to deliver a new flavor ­— our tropical Guava Passionfruit TruGels — so patients across the state would have an opportunity to try a new kind of relief themselves. With the addition of our TruChocolate bars and our first partner brand hitting our shelves, we are busily ramping for broadened, consistent statewide distribution in the coming weeks.”

Love’s Oven Executive Chef, Hope Frahm, added, “The team at Love’s Oven is so excited to be working with the Florida market leader, Trulieve, to introduce our brand of delicious baked goods to the great state of Florida.  We know the patients in Florida are going to enjoy our unique take on the traditional chocolate chip cookie and fudge brownie which are infused with cannabutter.  These aren’t your grandma’s cookies and brownies!  Trulieve launching Love’s Oven edible sales in Florida marks a historic day for us!”

Starting August 27, when the Florida Department of Health announced final guidelines, Trulieve began working on submissions to the state for approvals to start production of certain product lines. Trulieve has a 10,000 sq. ft. commercial-grade kitchen at its production facility, one of only four cannabis companies in the state with an approved kitchen.

About Love’s Oven
Love’s Oven™, along with other brands (Concentrated Love™, Sinsere Chocolates & Peace Mountain Edibles) is a manufacturer of cannabis infused pastries, confections, and concentrate products. Its proprietary THC & CBD extraction methods are designed to ensure each patient receives a consistent and effective dose of “Love” with every bite and hit of its edible or concentrate products.

About Trulieve

Trulieve is a vertically integrated “seed-to-sale” company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts, and Connecticut. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX Best Market under the symbol TCNNF.

This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

To learn more about Trulieve, visit

The Canadian Securities Exchange has not reviewed, approved or disapproved the ‎content of this news release.‎

Forward-Looking Statements
This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company and statements with regard to the Report and the Company’s response thereto. Words such as “expects”, “continue”, “will”, “anticipates” and “intends” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on the Company’s current projections and expectations about future events and financial trends that management believes might affect its financial condition, results of operations, business strategy and financial needs, and on certain assumptions and analysis made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors management believes are appropriate. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.

Cision View original content to download multimedia:

SOURCE Trulieve Cannabis Corp.

News Provided by PR Newswire via QuoteMedia


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.

Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.

Keep reading... Show less

The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement

Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination

Keep reading... Show less

Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising

Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.

In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.

Keep reading... Show less

Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.

Keep reading... Show less